JOHNS HOPKINS BAYVIEW MED. CTR. — History
CCN 210029 | 3-year financial timeline | COVID resilience: 40/100
🛡️ Public data only — no PHI permitted on this instance.
$654M
Latest Revenue (FY2022)
+1.3%
Revenue CAGR (3yr)
-17.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $638M | $660M | $654M | -0.9% | +1.3% |
| Operating Expenses | $701M | $767M | $766M | -0.0% | +4.6% |
| Operating Margin | -9.9% | -16.1% | -17.1% | -6.2% | +0.0% |
| Net Income | $-63M | $-106M | $-112M | -5.3% | +0.0% |
| Licensed Beds | 422 | 418 | 424 | +1.4% | +0.2% |
| Total Patient Days | 110,247 | 113,766 | 114,168 | +0.4% | +1.8% |
| Medicare Day % | 39% | 35% | 35% | +0.1% | -4.9% |
| Medicaid Day % | 5% | 16% | 15% | -7.3% | +83.2% |
COVID Impact & Recovery
Resilience Score: 40/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +2.6% ($638M → $654M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.3%
This Hospital
+7.6%
State Avg
Latest Margin
-17.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $663M | -20.7% |
| FY2024 (proj) | $671M | -24.3% |
| FY2025 (proj) | $680M | -27.9% |